A Small Molecule Trifunctional Ligand for Fibroblast Activation Protein-a (FAP)-Targeted Theranostics

被引：0
|
作者：
Kelly, J. M. [1 ]
Ponnala, S. [1 ]
Jeitner, T. M. [1 ]
Nikolopoulou, A. [1 ]
Williams, C., Jr. [1 ]
Hu, B. [1 ]
Babich, J. W. [1 ]
机构：
[1] Weill Cornell Med, New York, NY USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-439
引用
收藏
页码：S169 / S169
页数：1
相关论文
共 50 条
  • [1] A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα)
    Kelly, James M.
    Jeitner, Thomas M.
    Ponnala, Shashikanth
    Williams, Clarence, Jr.
    Nikolopoulou, Anastasia
    DiMagno, Stephen G.
    Babich, John W.
    MOLECULAR IMAGING AND BIOLOGY, 2021, 23 (05) : 686 - 696
  • [2] A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα)
    James M. Kelly
    Thomas M. Jeitner
    Shashikanth Ponnala
    Clarence Williams
    Anastasia Nikolopoulou
    Stephen G. DiMagno
    John W. Babich
    Molecular Imaging and Biology, 2021, 23 : 686 - 696
  • [3] Fibroblast activation protein (FAP)-targeted radionuclide therapy: which ligand is the best?
    Rubel Chakravarty
    Wenyu Song
    Sudipta Chakraborty
    Weibo Cai
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2935 - 2939
  • [4] Fibroblast activation protein (FAP)-targeted radionuclide therapy: which ligand is the best?
    Chakravarty, Rubel
    Song, Wenyu
    Chakraborty, Sudipta
    Cai, Weibo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (10) : 2935 - 2939
  • [5] Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP)
    De Decker, An
    Vliegen, Gwendolyn
    Van Rompaey, Dries
    Peeraer, Anke
    Bracke, An
    Verckist, Line
    Jansen, Koen
    Geiss-Friedlander, Ruth
    Augustyns, Koen
    De Winter, Hans
    De Meester, Ingrid
    Lambeir, Anne-Marie
    Van der Veken, Pieter
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (08): : 1173 - 1179
  • [6] Fibroblast Activation Protein Inhibitor Theranostics
    Raju, Shobhana
    Shukla, Jaya
    Kumar, Rakesh
    PET CLINICS, 2022, 17 (03) : 453 - 464
  • [7] Preclinical Development of PNT6555, a Boronic Acid-Based, Fibroblast Activation Protein-a (FAP)-Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors
    Poplawski, Sarah E.
    Hallett, Robin M.
    Dornan, Mark H.
    Novakowski, Kyle E.
    Pan, Shuang
    Belanger, Anthony P.
    Nguyen, Quang-De
    Wu, Wengen
    Felten, Albert E.
    Liu, Yuxin
    Ahn, Shin Hye
    Hergott, Valerie S.
    Jones, Barry
    Lai, Jack H.
    McCann, Joe A. B.
    Bachovchin, William W.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (01) : 100 - 108
  • [8] Enhancing fibroblast activation protein (FAP)-targeted radionuclide therapy with albumin binding, and beyond
    Younis, Muhsin H.
    Malih, Sara
    Lan, Xiaoli
    Rasaee, Mohammad Javad
    Cai, Weibo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (06) : 1773 - 1777
  • [9] Enhancing fibroblast activation protein (FAP)-targeted radionuclide therapy with albumin binding, and beyond
    Muhsin H. Younis
    Sara Malih
    Xiaoli Lan
    Mohammad Javad Rasaee
    Weibo Cai
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 1773 - 1777
  • [10] Fibroblast Activation Protein (FAP): an overview for trainees
    Yazdanpanah, Fereshteh
    Subtirelu, Robert
    Teichner, Eric
    Werner, Thomas
    Morris, Michael
    Revheim, Mona-Elisabeth
    Alavi, Abass
    Saboury, Babak
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
12345